Glatopa Approval History
- FDA approved: Yes (First approved April 16th, 2015)
- Brand name: Glatopa
- Generic name: glatiramer acetate
- Dosage form: Injection
- Company: Sandoz Inc.
- Treatment for: Multiple Sclerosis
Glatopa (glatiramer acetate) is a generic version of Copaxone, an immunomodulator drug for the treatment of patients with relapsing-forms of multiple sclerosis.
Development History and FDA Approval Process for Glatopa
|Apr 16, 2015||FDA Approves Glatopa (glatiramer acetate) as the First Generic Competitor to Copaxone|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.